1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global Terbium-149 Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Purity: >99%
  • 1.3.3 Purity: >98%
• 1.4 Market Analysis by Product Form
  • 1.4.1 Overview: Global Terbium-149 Consumption Value by Product Form: 2021 Versus 2025 Versus 2032
  • 1.4.2 Unlabeled Terbium-149 Radionuclide
  • 1.4.3 Terbium-149-labeled Intermediate
  • 1.4.4 Terbium-149 Radiopharmaceutical Preparation
• 1.5 Market Analysis by Production Technology Route
  • 1.5.1 Overview: Global Terbium-149 Consumption Value by Production Technology Route: 2021 Versus 2025 Versus 2032
  • 1.5.2 High-energy Proton Fission
  • 1.5.3 Heavy-ion Bombardment
  • 1.5.4 Cyclotron Production
• 1.6 Market Analysis by Radionuclide Quality Grade
  • 1.6.1 Overview: Global Terbium-149 Consumption Value by Radionuclide Quality Grade: 2021 Versus 2025 Versus 2032
  • 1.6.2 Research-grade Radionuclide
  • 1.6.3 Preclinical Drug-grade Radionuclide
• 1.7 Market Analysis by Application
  • 1.7.1 Overview: Global Terbium-149 Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.7.2 Cancer Treatment
  • 1.7.3 Scientific Research
• 1.8 Global Terbium-149 Market Size & Forecast
  • 1.8.1 Global Terbium-149 Consumption Value (2021 & 2025 & 2032)
  • 1.8.2 Global Terbium-149 Sales Quantity (2021-2032)
  • 1.8.3 Global Terbium-149 Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 TRIUMF
  • 2.1.1 TRIUMF Details
  • 2.1.2 TRIUMF Major Business
  • 2.1.3 TRIUMF Terbium-149 Product and Services
  • 2.1.4 TRIUMF Terbium-149 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 TRIUMF Recent Developments/Updates
• 2.2 CERN
  • 2.2.1 CERN Details
  • 2.2.2 CERN Major Business
  • 2.2.3 CERN Terbium-149 Product and Services
  • 2.2.4 CERN Terbium-149 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 CERN Recent Developments/Updates
• 2.3 J-PARC
  • 2.3.1 J-PARC Details
  • 2.3.2 J-PARC Major Business
  • 2.3.3 J-PARC Terbium-149 Product and Services
  • 2.3.4 J-PARC Terbium-149 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 J-PARC Recent Developments/Updates
• 2.4 RIBF
  • 2.4.1 RIBF Details
  • 2.4.2 RIBF Major Business
  • 2.4.3 RIBF Terbium-149 Product and Services
  • 2.4.4 RIBF Terbium-149 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 RIBF Recent Developments/Updates

3 Competitive Environment: Terbium-149 by Manufacturer

• 3.1 Global Terbium-149 Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global Terbium-149 Revenue by Manufacturer (2021-2026)
• 3.3 Global Terbium-149 Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of Terbium-149 by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 Terbium-149 Manufacturer Market Share in 2025
  • 3.4.3 Top 6 Terbium-149 Manufacturer Market Share in 2025
• 3.5 Terbium-149 Market: Overall Company Footprint Analysis
  • 3.5.1 Terbium-149 Market: Region Footprint
  • 3.5.2 Terbium-149 Market: Company Product Type Footprint
  • 3.5.3 Terbium-149 Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global Terbium-149 Market Size by Region
  • 4.1.1 Global Terbium-149 Sales Quantity by Region (2021-2032)
  • 4.1.2 Global Terbium-149 Consumption Value by Region (2021-2032)
  • 4.1.3 Global Terbium-149 Average Price by Region (2021-2032)
• 4.2 North America Terbium-149 Consumption Value (2021-2032)
• 4.3 Europe Terbium-149 Consumption Value (2021-2032)
• 4.4 Asia-Pacific Terbium-149 Consumption Value (2021-2032)
• 4.5 South America Terbium-149 Consumption Value (2021-2032)
• 4.6 Middle East & Africa Terbium-149 Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global Terbium-149 Sales Quantity by Type (2021-2032)
• 5.2 Global Terbium-149 Consumption Value by Type (2021-2032)
• 5.3 Global Terbium-149 Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global Terbium-149 Sales Quantity by Application (2021-2032)
• 6.2 Global Terbium-149 Consumption Value by Application (2021-2032)
• 6.3 Global Terbium-149 Average Price by Application (2021-2032)

7 North America

• 7.1 North America Terbium-149 Sales Quantity by Type (2021-2032)
• 7.2 North America Terbium-149 Sales Quantity by Application (2021-2032)
• 7.3 North America Terbium-149 Market Size by Country
  • 7.3.1 North America Terbium-149 Sales Quantity by Country (2021-2032)
  • 7.3.2 North America Terbium-149 Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe Terbium-149 Sales Quantity by Type (2021-2032)
• 8.2 Europe Terbium-149 Sales Quantity by Application (2021-2032)
• 8.3 Europe Terbium-149 Market Size by Country
  • 8.3.1 Europe Terbium-149 Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe Terbium-149 Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific Terbium-149 Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific Terbium-149 Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific Terbium-149 Market Size by Region
  • 9.3.1 Asia-Pacific Terbium-149 Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific Terbium-149 Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America Terbium-149 Sales Quantity by Type (2021-2032)
• 10.2 South America Terbium-149 Sales Quantity by Application (2021-2032)
• 10.3 South America Terbium-149 Market Size by Country
  • 10.3.1 South America Terbium-149 Sales Quantity by Country (2021-2032)
  • 10.3.2 South America Terbium-149 Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa Terbium-149 Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa Terbium-149 Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa Terbium-149 Market Size by Country
  • 11.3.1 Middle East & Africa Terbium-149 Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa Terbium-149 Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 Terbium-149 Market Drivers
• 12.2 Terbium-149 Market Restraints
• 12.3 Terbium-149 Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of Terbium-149 and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of Terbium-149
• 13.3 Terbium-149 Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 Terbium-149 Typical Distributors
• 14.3 Terbium-149 Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Terbium-149 market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
In 2025, global production of Terbium-149 is approximately 37 grams, with a global average market price of around $125,000 per gram. That year, total global production capacity for Terbium-149 reaches approximately 70 grams, and the industry's gross profit margin stands at about 54%. Terbium-149 (Tb-149) is an artificial radioisotope of the element terbium, characterized by an atomic number of 65, a mass number of 149, and a half-life of approximately 4.1 hours. Capable of emitting short-range alpha particles alongside a proportion of positrons, it holds potential for both targeted alpha therapy and PET imaging, making it one of the few radionuclides in nuclear medicine to possess this dual "therapy-plus-imaging" capability. Its alpha particles have an energy of approximately 3.97–3.98 MeV and a tissue range of tens of micrometers, allowing for high linear energy transfer within a localized area; theoretically, this makes it suitable for eliminating micrometastases, single tumor cells, or small tumor foci. Meanwhile, its positron emission offers prospects for PET-based monitoring of drug distribution and post-treatment dosimetry. Together with Terbium-152, Terbium-155, and Terbium-161, this group of terbium radionuclides covers the modalities of PET, SPECT, alpha therapy, and beta therapy.
The upstream segment of the industry chain primarily encompasses high-purity tantalum targets and other nuclear reaction target materials, high-energy proton accelerators, online or offline isotope mass separation equipment, ion sources, radiation shielding facilities, and radiochemical separation consumables. A currently established experimental production route involves bombarding tantalum targets with high-energy protons to generate fission or spallation products, isolating the nuclide with a mass number of 149 via ISOL (Isotope Separation On-Line) technology, and subsequently performing chemical purification. Due to Tb-149's short half-life, limited yield, and the potential presence of isobaric impurities during production, key upstream barriers center on access to high-energy accelerators, mass separation efficiency, radionuclide purity, and rapid transport capabilities. The midstream segment consists mainly of nuclear medicine research institutions, radiopharmaceutical laboratories, isotope separation platforms, and specialized radiochemistry teams; these entities are responsible for further purifying the accelerator-produced and isolated Tb-149, converting it into a chemical form suitable for labeling, and conjugating it with targeting vectors such as peptides, antibodies, or folic acid analogs. Terbium is a lanthanide metal capable of forming stable complexes with chelating agents such as DOTA, thereby enabling the development of radiopharmaceuticals linked to various targeting molecules. The midstream sector requires rigorous testing of parameters—including radionuclide purity, radiochemical purity, specific activity, sterility, endotoxin levels, stability, and labeling efficiency—alongside the completion of production, quality control, and distribution within a very short timeframe. Given that Terbium-149 has a half-life of only about four hours, its commercialization relies heavily on close coordination between production facilities, radiopharmaceutical preparation centers, and clinical hospitals; currently, activities remain primarily focused on experimental batches and research projects. The downstream sector of the industry chain encompasses major oncology hospitals, nuclear medicine centers, clinical trial sites for radiopharmaceuticals, and cancer biology research institutions. The core potential application of Terbium-149 lies in conjugating it with specific targeting molecules to treat tumors expressing corresponding receptors or antigens—particularly micro-lesions, disseminated tumor cells, and micrometastases. Simultaneously, its positron-emitting capability allows for PET imaging to monitor the drug's distribution in vivo, providing supplementary data for treatment verification and dosimetry assessment. Research has explored targeting strategies involving folate receptors, peptides, and antibodies; however, the large-scale clinical application of Terbium-149 remains constrained by factors such as production yield, logistical radius, standardized preparation, patient dosimetry, and regulatory approval.
The rising demand for targeted alpha therapy is the primary driver behind the continued development of Terbium-149 (Tb-149). Tb-149 emits alpha particles characterized by high linear energy transfer (LET) and a short tissue range; theoretically, it is well-suited for eliminating micrometastatic lesions, individual tumor cells, and disseminated metastases, with targeted delivery achievable via antibodies, peptides, or small-molecule carriers. As nuclear medicine evolves from traditional external beam radiation and beta-emitter therapies toward highly selective targeted alpha therapy, research institutions are seeking novel radionuclides that combine high cytotoxic efficacy with a controllable range of tissue damage. Existing studies demonstrate the potential of Tb-149 in folate receptor- and antibody-targeted therapies, with experimental evidence confirming its ability to kill single cells; consequently, its long-term value hinges on advancements in novel targeting molecules, indication selection, and clinical dosimetry research.
The potential for "theranostic" integration—combining alpha therapy with PET imaging—serves as a key development driver distinguishing Tb-149 from most other alpha-emitting radionuclides. In addition to alpha decay, Tb-149 exhibits positron emission properties, theoretically allowing a single radionuclide to perform both therapy and PET tracing; this enables the monitoring of a radiopharmaceutical's in vivo distribution, targeting efficiency, and uptake in non-target organs. This "Alpha-PET" model promises to minimize discrepancies in chemical properties, pharmacokinetics, and tissue distribution between diagnostic and therapeutic radionuclides, thereby providing more direct data to support patient selection, personalized dosimetry, and post-treatment verification. Furthermore, the suite of terbium radionuclides—comprising Tb-149, Tb-152, Tb-155, and Tb-161—covers applications ranging from PET and SPECT imaging to various forms of particle therapy, facilitating the platform-based development of terbium-based radiopharmaceuticals. The IAEA’s launch of a collaborative research project on terbium-based radiopharmaceuticals for 2026 underscores the international nuclear medicine community's commitment to standardized cooperation regarding production, quality control, and integrated theranostic applications.
Technological trends in the industry will focus primarily on enhancing production yields and radionuclide purity, as well as ensuring the reproducibility of production pathways. Currently, Terbium-149 is primarily produced by bombarding tantalum targets with high-energy protons and employing on-line mass separation; this process places stringent demands on accelerator energy, target stations, ion sources, and mass separation facilities, limiting the number of institutions worldwide capable of stable experimental production. Research conducted in 2024 optimized the ISOLDE production, separation, and purification workflows, boosting the yield of Terbium-149 to a maximum of approximately 260 MBq per batch and achieving a radionuclidic purity exceeding 99%, signaling a transition from low-yield fundamental experiments to the production of batches suitable for preclinical use. Future efforts will explore alternative routes—such as bombarding samarium targets with heavy ions—alongside techniques like laser resonance ionization, the use of more efficient target materials, and rapid radiochemical purification, all aimed at minimizing isobaric impurities and enhancing the capacity for reproducible supply. Research on heavy-ion reactions with samarium targets, made public in 2025, further demonstrates the industry's pursuit of alternative production pathways that bypass the limitations associated with a small number of large-scale ISOL facilities.
Report Scope
This report is a detailed and comprehensive analysis for global Terbium-149 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Terbium-149 market size and forecasts, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Terbium-149 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Terbium-149 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Gram), and average selling prices (US$/g), 2021-2032
Global Terbium-149 market shares of main players, shipments in revenue ($ Million), sales quantity (Gram), and ASP (US$/g), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Terbium-149
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Terbium-149 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include TRIUMF, CERN, J-PARC, RIBF, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Terbium-149 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Purity: >99%
Purity: >98%
Market segment by Product Form
Unlabeled Terbium-149 Radionuclide
Terbium-149-labeled Intermediate
Terbium-149 Radiopharmaceutical Preparation
Market segment by Production Technology Route
High-energy Proton Fission
Heavy-ion Bombardment
Cyclotron Production
Market segment by Radionuclide Quality Grade
Research-grade Radionuclide
Preclinical Drug-grade Radionuclide
Market segment by Application
Cancer Treatment
Scientific Research
Major players covered
TRIUMF
CERN
J-PARC
RIBF
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Terbium-149 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Terbium-149, with price, sales quantity, revenue, and global market share of Terbium-149 from 2021 to 2026.
Chapter 3, the Terbium-149 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Terbium-149 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Terbium-149 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Terbium-149.
Chapter 14 and 15, to describe Terbium-149 sales channel, distributors, customers, research findings and conclusion.